A Clinical trial to study the effect of Bhummyamalaki ghan vati in the management of Amlapitta.

"A RANDOMIZED, OPEN LABELLED,CONTROLLED CLINICAL TRIAL OF EFFICACY OF BHUMMYAMALAKI (Phyllanthus niruri Linn. )GHAN VATI IN THE MANAGEMENT OF URDHWAG AMLAPITTA ." - ROCA

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/028161

Enrollment

Registered

2020-09-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

Intervention1: Bhummyamalaki ghan vati: Bhummyamalaki Ghan vati-500mg with lukewarm water Vyaan-udane(twice after meals)along with pathya-apathya Duration-28days Control Intervention1: Drakshadi Gutik

Eligibility

Inclusion criteria

Inclusion criteria: Maximum duration of symptoms is 6months. Patients having symptoms of Hrutkanthadaha and any other two symptoms described by Madhavnidan will diagnosed as Urdhwag Amlapitta

Exclusion criteria

Exclusion criteria: Pregnant and lactating mother Chronic alcohol addiction Already diagnosed cases of Peptic Ulcer Other major illness

Design outcomes

Primary

Measure	Time frame
Decrease in gradations of symptoms of Amlapitta as told in MadhavnidanTimepoint: 28days	—

Secondary

Measure	Time frame
To study the different ecological factor of Amlapitta according to Ayurveda To study the pathophysiology of Amlapitta according to Ayurvedic as well as conventional scienceTimepoint: 28days	—

Countries

India

Contacts

Public ContactVd Prasad Kulkarni

Government Ayurved College Nanded

kulk.prasad1@gmail.com9405365096

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026